Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
-.--%-.--%-18.2x89.81x40.62x-19.98x-19.74x 1.84TCr
-.--%-.--%47.53x5.13x8.06x35.89x37.15x 3.35TCr
1.69%1.94%17.11x3x4.21x11.48x13.45x 2.79TCr
-.--%-.--%-23.26x1.25x5.74x-9.34x-8.02x 2.71TCr
-.--%-.--%-52.36x - - -52.6x-51.7x 1.68TCr
-.--%-.--%23.73x1.97x4.15x12.05x15.41x 1.3TCr
-.--%-.--%2026.06x13.42x26.15x298.85x1309.26x 1.29TCr
-.--%-.--%12.7x1.96x2.42x6.92x7.46x 1.27TCr
-.--%-.--%19.23x4.32x4.61x13.26x13.84x 1.2TCr
-.--%-.--%-119.06x25.66x36.83x-204.43x-113.33x 1.03TCr
-.--%-.--%-38.7x6.65x5.95x-49.53x-41.59x 661.04Cr
-.--%-.--%-22.64x12.26x8.7x-15.41x-17.7x 642.05Cr
-.--%-.--%30.16x5.48x10.04x31.44x34.02x 606.37Cr
0.31%0.41%57.66x1.94x3.51x15.94x29.13x 578.9Cr
-.--%-.--%-15.74x6.32x - -16.77x-14.51x 559.61Cr
-.--%-.--%-36.36x21.24x15.84x-66.29x-49.23x 496.32Cr
Average 0.13% 0.15% 119.24x 13.36x 12.63x -0.53x 71.49x 1.37TCr
Weighted average by Cap. 0.22% 0.26% 116.97x 13.73x 12.16x 7.35x 72.95x
Bio Therapeutic Drugs